These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 772559)

  • 1. Physical and chemical properties of normal and haemophilic factor VIII.
    Vermylen J
    Pathol Biol (Paris); 1975 Dec; 23 suppl():5-10. PubMed ID: 772559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The functional defect of factor VIII Leiden, a genetic variant of coagulation factor VIII.
    Mertens K; van Wijngaarden A; Bertina RM; Veltkamp JJ
    Thromb Haemost; 1985 Oct; 54(3):650-3. PubMed ID: 3937262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The different action of bovine and human factor VIII (anti-haemophilic globulin) on factor X consumption during coagulation].
    Mayer G; Mayer S; Waitz R
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1028-31. PubMed ID: 5377890
    [No Abstract]   [Full Text] [Related]  

  • 6. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA; Andersen JC; Pizzo SV; McKee PA
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor).
    Beck EA; Bachmann P; Barbier P; Furlan M
    Thromb Haemost; 1976 Feb; 35(1):186-90. PubMed ID: 1085500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
    Over J; Bouma BN; Sixma JJ; Bolhuis PA; Vlooswijk RA
    J Lab Clin Med; 1980 Mar; 95(3):323-34. PubMed ID: 7354239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-damping mechanism in blood coagulation.
    Nemerson Y; Silverberg SA; Jesty J
    Thromb Diath Haemorrh; 1974 Sep; 32(1):57-64. PubMed ID: 4454045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates.
    Rosén S
    Thromb Haemost; 2001 Oct; 86(4):1132-3. PubMed ID: 11686346
    [No Abstract]   [Full Text] [Related]  

  • 13. Is hemophilia a disease of the tissue factor pathway of coagulation?
    Nemerson Y; Zur M
    Prog Clin Biol Res; 1981; 72():77-83. PubMed ID: 6801686
    [No Abstract]   [Full Text] [Related]  

  • 14. Factor VIII S373L: mutation at P1' site confers thrombin cleavage resistance, causing mild haemophilia A.
    Johnson DJ; Pemberton S; Acquila M; Mori PG; Tuddenham EG; O'Brien DP
    Thromb Haemost; 1994 Apr; 71(4):428-33. PubMed ID: 8052958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.
    Switzer ME; McKee PA
    J Clin Invest; 1976 Apr; 57(4):925-37. PubMed ID: 1084890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adsorption of coagulation factors onto phospholipids. Its role in the reaction mechanism of blood coagulation.
    Hemker HC; Kahn MJ; Devilee PP
    Thromb Diath Haemorrh; 1970 Oct; 24(1):214-23. PubMed ID: 4320747
    [No Abstract]   [Full Text] [Related]  

  • 17. Factor VIII-factor IX interactions: molecular sites involved in enzyme-cofactor complex assembly.
    Mertens K; Celie PH; Kolkman JA; Lenting PJ
    Thromb Haemost; 1999 Aug; 82(2):209-17. PubMed ID: 10605706
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular mechanisms in blood coagulation.
    Davie EW; Kirby EP
    Curr Top Cell Regul; 1973; 7():51-86. PubMed ID: 4592483
    [No Abstract]   [Full Text] [Related]  

  • 19. Factor VIII procoagulant protein.
    Zimmerman TS; Fulcher CA
    Clin Haematol; 1985 Jun; 14(2):343-58. PubMed ID: 3930116
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of heparin in intrinsic blood coagulation.
    Pitlick FA; Lundblad RL; Davie EW
    J Biomed Mater Res; 1969 Mar; 3(1):95-106. PubMed ID: 5784970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.